¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"combined androgen blockade"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® androgen ÇÑ±Û ³²¼ºÈ£¸£¸ó, ¾Èµå·Î°Õ
¼³¸í   
  ³²¼ºÀÇ ÀÌÂ÷ ¼ºÂ¡À» ³ªÅ¸³»°Ô Çϴ ȣ¸£¸ó. Å×½ºÅ佺Å×·Ð(testosterone), ¾Èµå·Î½ºÅ×·Ð(androsterone) µîÀÌ ÀÖ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • blockade
    Â÷´Ü
  • ganglionic blockade
    ½Å°æÀýÂ÷´Ü
  • androgen
    1. ³²¼ºÈ£¸£¸ó 2. ¾Èµå·Î°Õ
  • androgen binding protein
    ¾Èµå·Î°Õ°áÇմܹéÁú
  • androgen receptor
    ¾Èµå·Î°Õ¼ö¿ëü
  • combined anesthesia
    º´¿ë¸¶Ãë
  • combined aphasia
    º¹ÇÕ¾ð¾î»ó½ÇÁõ, º¹ÇսǾîÁõ
  • combined effect
    º´¿ëÈ¿°ú
  • combined examination
    µÎ¼ÕÁøÂû, ³»Áø
  • combined hyperlipidemia
    º¹ÇÕ°íÁöÁúÇ÷Áõ
  • combined immunodeficiency
    º¹Çո鿪°áÇÌ
  • combined immunodeficiency disease
    º¹Çո鿪°áÇ̺´
  • combined immunodeficiency syndrome
    º¹Çո鿪°áÇÌÁõÈıº
  • combined impression
    ¿¬ÇÕÀλó
  • combined manual reposition
    µ¿¹Ýµµ¼öÁ¤º¹
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • blockade
    Â÷´Ü
  • androgen
    1.³²¼ºÈ£¸£¸ó, 2.¾Èµå·Î°Õ
  • total androgen
    ÃѾȵå·Î°Õ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • androgen
    ¾Èµå·Î°Õ, ³²¼ºÈ£¸£¸ó
  • androgen receptor
    ¾Èµå·Î°Õ¼ö¿ëü
  • blockade
    Â÷´Ü
  • ganglionic blockade
    ½Å°æÀýÂ÷´Ü
  • combined anesthesia
    º´ÇึÃë
  • combined aphasia
    º¹ÇÕ¾ð¾î»ó½ÇÁõ
  • combined effect
    º´¿ëÈ¿°ú
  • combined examination
    (¢¡bimanual examination) µÎ¼ÕÁøÂû, ³»Áø
  • combined hyperlipidemia
    º¹ÇÕ°íÁöÁúÇ÷Áõ
  • combined immunodeficiency
    º¹Çո鿪°áÇÌ
  • combined impression
    ¿¬ÇÕÀλó
  • combined nevus
    º¹ÇÕ¸ð¹Ý
  • combined pregnancy
    °âÇÑÀÓ½Å
  • combined scintiscan
    º´Çսů¼½ºÄµ, º´ÇÕ¼¶±¤½ºÄµ
  • combined sclerosis
    (¢¡subacute combined degeneration) ¾Æ±Þ¼º¿¬ÇÕº¯¼º
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • SCID= Severe combined mmunodeficiency
    ÁßÁõÈ¥Çո鿪°áÇÌÁõ.
  • immunodeficiency syndrome, severe combined
    ÁßÁõº¹ÇÕÇü ¸é¿ª°áÇÌ ÁõÈıº
  • MAC-BAR(minimum alveolar concentration-blockade of autonomic response)
    ÀÚÀ²½Å°æ¾ïÁ¦ ÃÖ¼ÒÆóÆ÷³»³óµµ
  • ganglionic blockade
    ½Å°æÀýÂ÷´Ü<ºÀ¼â>(¡­ó´Ó¨<Üæáð>).
  • ganglionic blockade
    ½Å°æÀýÂ÷´Ü(¡­ó´Ó¨).
  • receptor blockade
    ¼ö¿ëüÂ÷´Ü
  • renal blockade
    ½ÅÂ÷´Ü(ãìó´Ó¨).
  • ABP=> androgen-binding protein
    ¾Èµå·ÎÁ¨°áÇմܹé
  • androgen
    ¾Èµå·Î°Õ
  • androgen
    ³²¼ºÈ£¸£¸ó, ¾Èµå·Î°Õ, ¾Èµå·ÎÁ¨
  • androgen
    ¾Èµå·Î°Õ, ³²¼ºÈ£¸£¸ó(Ñûàõ¡­)
  • androgen
    ³²¼ºÈ£¸£¸ó, ¾Èµå·Î°Õ.
  • androgen antagonist
    ³²¼ºÈ£¸£¸ó ±æÇ×Á¦
  • androgen insensitivity
    ³²¼ºÈ£¸£¸ó ¹«°¨ÀÀ
  • androgen insensitivity syndrome
    ¾Èµå·Î°Õ( ³²¼ºÈ£¸£¸ó) ºÒ°¨¼º ÁõÈıº(ÝÕÊïàõ ñøý¦ÏØ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • androgen
    ³²¼ºÈ£¸£¸ó, ¾Èµå·Î°Õ, ¾Èµå·ÎÁ¨
  • androgen
    ¾Èµå·Î°Õ, ³²¼ºÈ£¸£¸ó(Ñûàõ¡­)
  • androgen
    ³²¼ºÈ£¸£¸ó, ¾Èµå·Î°Õ.
  • androgen
    ¾Èµå·Î°Õ
  • androgen antagonist
    ³²¼ºÈ£¸£¸ó ±æÇ×Á¦
  • androgen insensitivity
    ³²¼ºÈ£¸£¸ó ¹«°¨ÀÀ
  • androgen insensitivity syndrome
    ¾Èµå·Î°Õ( ³²¼ºÈ£¸£¸ó) ºÒ°¨¼º ÁõÈıº(ÝÕÊïàõ ñøý¦ÏØ)
  • androgen receptor
    ³²¼ºÈ£¸£¸ó ¼ö¿ëü
  • androgen therapy
    ³²¼ºÈ£¸£¸ó ¿ä¹ý
  • androgen, androgenic steroid
    ³²¼º(È­)È£¸£¸ó, ³²¼ºÈ­½ºÅ×·ÎÀ̵å.
  • androgen- binding protein
    ¸¸¼ºÈ£¸£¸ó °áÇմܹé
  • androgen-resistance syndrome
    ³²¼ºÈ£¸£¸ó ³»¼º(ÀúÇ×)ÁõÈıº?
  • block/blockade
    Â÷´Ü.
  • blockade
    ºÀ¼â, Â÷´Ü, ºÀ¼âÁ¦, Â÷´ÜÁ¦.
  • blockade narcotic
    ¸¶¾à¼º Â÷´Ü.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • combined acidity
    º¹Çջ굵(ÜÜùê߫Ӹ)
  • androgen
    ¾Èµå·ÎÀü
  • androgen-binding protein
    ¾Èµå·ÎÀü°áÇÕ(Ì¿ùê) ´Ü¹éÁú(Ó±ÛÜòõ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • androgen
    ³²¼ºÈ£¸£¸ó, ¾Èµå·Î°Õ
  • blockade
    ºÀ¼â, Â÷´Ü, ºÀ¼âÁ¦, Â÷´ÜÁ¦
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
BB bad breath; bed bath; beta blockade, beta blocker; BioBreeding [rat]; blanket bath; blood bank; bloo...
NMB neuromedin B; neuromuscular blockade; neuromuscular blocking; neuromuscular blocker/blocking [drug, ...
AIS Androgen Insensitive Syndrome
  = Testicular Feminization Syndrome
AA abdominal aorta; acetic acid; achievement age; active alcoholic; active assistive [range of motion];...
AACSH adrenal androgen corticotropic stimulating hormone
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CAB Combined androgen blockade
MAB Maximal androgen blockade
TAB Total androgen blockade
NMB Neuromuscular blockade
AB autonomic blockade
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • androgen
    ³²¼º È£¸£¸ó, ¾Èµå·Î°Õ
    1. ³²¼ºÈ­ ÀÛ¿ëÀ» °¡Áø ¹°Áú. 2. ³²¼º È£¸£¸óÀ» ÅëÅо ºÎ¸£´Â À̸§. °íȯ¿¡¼­ ºÐºñµÇ´Â ³²¼º È£¸£¸óÀ¸·Î´Â testosterone, dihydrotestosterone ¹× androstenedion µîÀÌ ÀÖ´Ù. ÀÌÁß¿¡¼­µµ testosteroneÀÇ ºÐºñ·®ÀÌ °¡Àå ¸¹°í ³²¼º È£¸£¸óÀÇ È¿´Éµµ °¡Àå °­ÇÏ´Ù.
  • androgen binding protein
    ³²¼º È£¸£¸ó °áÇÕ ´Ü¹é
  • androgen insensitivity syndrome
    ¾Èµå·Î°Õ ºÒ°¨¼º ÁõÈıº
  • androgen resistance syndrome
    ³²¼º È£¸£¸ó ³»¼º ÁõÈıº, ³²¼º È£¸£¸ó ÀúÇ× ÁõÈıº
  • blockade
    ºÀ¼â, Â÷´Ü
    1. Ä«¸£¹ÎÀ̳ª ź¼Ò ÀÔÀÚ¿Í °°Àº ¹«ÇØÇÑ ¹°ÁúÀ» Á¤¸Æ³»·Î ÁÖÀÔÇÏ¿© »ýü³» ¼¼¸Á ³»ÇǼ¼Æ÷ÀÇ ½ÄÀÛ¿ëÀ» ÀúÇϽÃŰ´Â °Í. 2. ¾à¹°·Î »ý¸®Àû ¶Ç´Â È¿¼Ò ÀÛ¿ëÀ» ÀúÁöÇÏ´Â °Í. 3. ¾à¹°·Î ´Ù¸¥ ¾à¹°ÀÇ È¿·ÂÀ» ÀúÁöÇÏ´Â °Í. ¿¹ÄÁ´ë Çì·ÎÀÎ ÀÛ¿ë¿¡ ´ëÇÑ ³¯·ÎÇÉÀÇ ¾ïÁ¦ ÀÛ¿ë. 4. Â÷´Ü¾à, ºÀ¼â¾à.
  • myoneural blockade
    ½Å°æ±Ù Â÷´Ü
  • narcotic blockade
    ¸¶¾à¼º Â÷´Ü
  • neurolytic blockade
    ½Å°æ ¿ëÇØ¼º Â÷´Ü
  • paravertebral blockade
    ôÃß ÁÖÀ§ Â÷´Ü
  • selective local anesthetic blockade
    ¼±ÅÃÀûÀÎ ±¹¼Ò ¸¶Ãë
  • combined aphasia
    ÇÕº´¼º ½Ç¾î
    µ¿ÀÏÇÑ »ç¶÷¿¡°Ô µ¿½Ã¿¡ ÀϾ´Â µÎ °¡Áö ÇüÅ ÀÌ»óÀÇ ½Ç¾îÁõ.
  • combined deafness
    È¥ÇÕ ³­Ã», È¥ÇÕ¼º ³­Ã»
  • combined examination.
    ¾ç¼Õ ÁøÂû
  • combined hyperlipidemia
    º¹ÇÕ¼º °íÁöÇ÷Áõ
  • combined immunodeficiency disease
    º¹ÇÕÇü ¸é¿ª °áÇÌ Áúȯ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
adrenergic blockade Selective inhibition by a drug of the responses of effector cells to adrenergic sympathetic nerve impulses (sympatholytic) and to epinephrine and related amines (adrenolytic).
(05 Mar 2000)
blockade 1. Intravenous injection of large amounts of colloidal dyes or other substances whereby the reaction of the reticuloendothelial cells to other influences (e.g., by phagocytosis) is temporarily prevented.
2. Arrest of peripheral nerve conduction or transmission at autonomic synaptic junctions, autonomic receptor sites, or myoneural junctions by a drug.
(05 Mar 2000)
ganglionic blockade Inhibition of nerve impulse transmission at autonomic ganglionic synapses by drugs such as nicotine or hexamethonium.
(05 Mar 2000)
virus blockade The interference of one virus by another, either attenuated or unrelated.
(05 Mar 2000)
cholinergic blockade Inhibition by a drug of nerve impulse transmission at autonomic ganglionic synapses (ganglionic blockade), at postganglionic parasympathetic effector cells (e.g., by atropine), and at myoneural junctions (myoneural blockade), the inhibition of a cholinergic agent.
(05 Mar 2000)
myoneural blockade Inhibition of nerve impulse transmission at myoneural junctions by a drug such as curare.
(05 Mar 2000)
narcotic blockade The use of drugs to inhibit the effects of narcotic substances, as with naloxone.
(05 Mar 2000)
neuromuscular blockade The intentional interruption of transmission at the neuromuscular junction by external agents, usually neuromuscular blocking agents. It is distinguished from nerve block in which nerve conduction is interrupted rather than neuromuscular transmission. Neuromuscular blockade is commonly used to produce muscle relaxation as an adjunct to anaesthesia during surgery and other medical procedures. It is also often used as an experimental manipulation in basic research. It is not strictly speaking anaesthesia but is grouped here with anaesthetic techniques. The failure of neuromuscular transmission as a result of pathological processes is not included here.
(12 Dec 1998)
sympathetic blockade Interruption of transmission in sympathetic ganglia or conduction of impulses in pre-or postganglionic sympathetic nerve fibres.
(05 Mar 2000)
adrenal androgen Any androgenic hormone of adrenocortical origin; e.g., dehydroepiandrosterone (and its sulfate), androstenedione, 11b-hydroxyandrostenedione.
(05 Mar 2000)
adrenal androgen-stimulating hormone A putative pituitary hormone that may be responsible for increased secretion of adrenal androgens at the time of puberty.
(05 Mar 2000)
androgen <endocrinology> General term for any male sex hormone in vertebrates. Androgens may be used in patients with breast cancer to treat recurrence of the disease.
(14 May 1997)
androgen antagonists Compounds which inhibit or antagonise the biosynthesis or actions of androgens.
(12 Dec 1998)
androgen binding protein A protein secreted by testicular Sertoli cells along with inhibin and mullerian inhibiting substance. Androgen binding protein probably maintains a high concentration of androgen in the seminiferous tubules.
(05 Mar 2000)
androgen-binding proteins Carrier proteins produced in the sertoli cells of the testis, secreted into the seminiferous tubules, and transported via the efferent ducts to the epididymis. Participate in the transport of androgens; include also synthetic androgens binding proteins.
(12 Dec 1998)
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
combined androgen blockade treatment of prostate cancer by blocking both testicular and adrenal androgens, usually through orchiectomy followed by administration of an agent that blocks adrenal androgens.
Ãâó: www.mercksource.com/pp/us/cns/cns_hl_dorlands.jspz...
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • androgen
    ¾Èµå·Î°Õ(³²¼º È£¸£¸ó)
  • combined
    °áÇÕµÈ;ÇÕµ¿ÀÇ;¿¬ÇÕÀÇ;È­ÇÕÇÑ
  • combined arms
    Á¦º´ ¿¬Çպδë(±â°©.º¸º´.Æ÷º´.°øº´.Ç×°øºÎ´ë µîÀ» ÅëÇÕÇÑ ÀÛÀü ºÎ´ë)
  • combined operations (exercises)
    ¿¬ÇÕ ÀÛÀü
  • blockade
    ºÀ¼â
  • blockade
    ºÀ¼â;Æó¼â;±³ÅëÂ÷´Ü;°æÁ¦ºÀ¼â
  • economic blockade
    °æÁ¦ ºÀ¼â
  • food blockade
    ½Ä·®ºÀ¼â
  • pacific blockade
    Æò½Ã ºÀ¼â
  • paper blockade
    (¼±¾ð¿¡ ±×Ä¡´Â)Áö»óºÀ¼â
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á